On September 9, a post went around. More than half a million people saw it. The account was one of the bio/acc handles, and it listed what is coming: baldness solved; a hundred-year lifespan; testosterone back to 1970s levels; aging half-reversed within ninety days; a full-body health scan in sixty seconds; an average IQ gain of thirty-five points once germline editing becomes routine.
It ended with five words: Don't give up now.
I understand the pull of that sentence. If you are sick, or aging, or lying awake certain you have run out of road, "the best days are almost here" is a dignified kind of comfort. So I am not here to laugh at the list. I am here to take it apart and see where each item actually stands. Real comfort survives being checked. If it doesn't survive, it was only borrowing your time.
Start with "aging half-reversed within ninety days." There is no human data for this. None. The first clinical trial is called ER-100, and it uses partial epigenetic reprogramming: three Yamanaka factors (OCT4, SOX2, KLF4) delivered into cells, switched on for a controlled window. The first participant was dosed on June 9, 2026. Eighteen people at most. One eye each, because the eye is easy to reach and easy to measure. The goal is safety, not rejuvenation, and the primary results are not due until May 2027.
What humanity actually has is two data points. A nine-person trial in 2019 that rolled epigenetic age back by about 1.5 years, with no control group. And CALERIE, where 220 people on long-term calorie restriction slowed the pace of aging by 2 to 3 percent. Slowed. Not reversed. "Ninety days for half" is not exactly a lie. It is a result from the next generation, pasted into your next three years.
"Testosterone back to 1970s levels" is the one with the most behind it. In July 2026, at a conference in London, Hagai Levine's team pooled six longitudinal studies covering 118,593 men from 1972 to 2019 and found average testosterone down 54 percent, roughly one percent a year. But that analysis has not been peer-reviewed, and more importantly nobody agrees on why. Obesity and metabolic disease probably explain a quarter to a half of it; the evidence for endocrine-disrupting chemicals is described as inconsistent. Dragging a population-wide trend back to 1970 is not a technology that is about to arrive. It is a fight with no identified enemy. And taking testosterone makes your body produce less of its own.
"A full-body scan in sixty seconds" has already arrived, just not in that shape. What you can buy is a whole-body MRI: forty minutes and about $2,500. The American College of Radiology, the American Cancer Society, and the Canadian Association of Radiologists all advise against it for people without symptoms. Ninety-four percent of those scanned have at least one finding, and nearly all of them are benign. What that buys you is biopsies, follow-ups, sleepless nights and bills. The technology is not the missing piece. The harder answer is the one nobody has: once you find it, should you treat it?
"An average IQ gain of thirty-five points" is the furthest away. The most-cited study on the subject found that picking the highest-scoring embryo, using the polygenic scores available at the time, would buy about 2.5 IQ points. The family data is colder still: in 28 large families, the top-scoring sibling was actually the tallest in only 7 of them. Thirty-five is fourteen times 2.5. And editing human embryos in a way that carries down the generations is illegal almost everywhere.
So what is the list, then? Not a lie. A schedule that pulls the best day forward into today. And its most valuable part is not the six items at all. It is the last line. That part is true. Only the reason needs replacing.
Because every item on that list answers one question: how much longer can you live. Not one of them answers a second question: how much of what you have already lived is still here.
Do you know your grandmother's maiden name? Do you know which street your father grew up on? Do you remember the song your mother hummed while she cooked, or what your grandfather did for a living before the job he retired from? Technology can patch your telomeres. It can scan your whole body. It can choose the genes of a child you have not had. It cannot fix one line of this. Your memory does not live in your cells. It lives in a few sentences that only you can still say, and those sentences are leaving you faster than your testosterone ever will.
The list gives you three to five years, as if all you need to do is hold out until the technology arrives. But there is a real deadline, and it is shorter than three to five years. It is the years in which you can still tell it clearly. The year your grandfather could still name the street. The year your mother could still hum the tune. After that it is gone — not lost to death, just gone while everyone is still alive.
3026 does not promise you a hundred years, and it will not make you young again. It does one small thing: it keeps what you write down now. One sentence is enough.
Three thousand years from now, someone will read you. By then they will probably have everything on that list: no baldness, a sixty-second scan, a hundred years as ordinary as breakfast. But they will stop at your sentence, because it was written by a real person, on one real day, who thought carefully about what to leave behind.
So let me finish that sentiment properly. Don't give up — but don't wait, either. The technology decides how long your body lasts. Only you decide what you leave in the time you get.
https://3026alive.com